My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2008-04-15_REVISION - M1980244 (315)
DRMS
>
Day Forward
>
Revision
>
Minerals
>
M1980244
>
2008-04-15_REVISION - M1980244 (315)
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/15/2021 5:52:12 PM
Creation date
5/12/2008 10:32:20 AM
Metadata
Fields
Template:
DRMS Permit Index
Permit No
M1980244
IBM Index Class Name
REVISION
Doc Date
4/15/2008
Doc Name
VOL VII APP 12 CERP Appendix IV Cyanide MSDS
From
CC & V
To
DRMS
Type & Sequence
AM9
Media Type
D
Archive
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
16
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
FIRST AID MEASiJRE$(continued) <br />• Antidotal Effects Section). <br />If symptoms persist or recur after the initial treatment, repeat <br />the antidote at one half the original doses one hour after the <br />original administration. Monitor methemoglobin levels when <br />practical in every patient treated with. the intravenous antidote. <br />AVOID OVER-TREATMENT. <br />The above sodium nitrite injection discussed in the Medical <br />Treatment Procedure Section is about one-third the lethal dose, so <br />care should be taken to avoid excessive use. It is not essential <br />that full quantities of antidote be given just because treatment <br />was started. Should injection be stopped for any reason, keep <br />track of the amount administered in case treatment needs to be <br />restarted. <br />ANTIDOTAL EFFECTS <br />Nitrites can produce hypotension through peripheral vasodilatation <br />(widening of the blood vessels). Methemoglobin formation, <br />although considered a therapeutic effect, may cause symptoms if <br />levels exceed 20-30%. Recommended intravenous doses of sodium <br />nitrite discussed in the Medical Treatment Procedure Section <br />usually produce methemoglobin levels under 20%.. Headache, nausea, <br />vomiting, -and syncope (fainting) may follow nitrite <br />administration, and syncope may occur ifi the patient is not lying <br />down. While it is important to be aware of the effects from <br />• nitrite therapy, there have been no long-lasting effects <br />associated with this treatment regimen for cyanide exposure in <br />DuPont's experience and knowledge. <br />RECOVERY AND DISPOSITION <br />For most accidental poisonings, patients can be revived in a flew <br />minutes using oxygen and amyl nitrite with complete recovery <br />within a few hours. <br />If necessary, the patient should be monitored for 24-48 hours. <br />Any patient whose symptoms require the use of IV antidote should <br />be considered for admittance to an intensive care unit. <br />Observe for return of symptoms. Monitor methemoglobin levels, <br />blood pH and oxygenation through arterial blood gas analysis. <br />Calculate anion gap from serum electrolytes. Cyanide poisoning <br />causes lactate accumulation and an anion gap metabolic acidosis. <br />Delayed neurotoxic efifiects are not expected consequences of <br />cyanide exposure although neurotoxic effects may occur if hypoxia <br />(oxygen deficiency) was prolonged. or occurred following massive <br />cyanide exposure. <br />In the presence of smoke inhalation that can occur during fires, <br />withholding amyl nitrite or sodium nitrite administration should <br />be considered because ofi the potential for high carboxyhemoglobin <br />levels. However, administration of oxygen and possibly sodium <br />thiosulfate should be continued. <br />(Continued) <br />1252CR Page 9 <br />
The URL can be used to link to this page
Your browser does not support the video tag.